• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500AJ23
Device Problems Degraded (1153); Fluid/Blood Leak (1250); Gradient Increase (1270); Device Stenosis (4066)
Patient Problems Dyspnea (1816); Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
Event Type  Injury  
Manufacturer Narrative
The device was not returned to edwards for evaluation as it remains implanted.Attempts to retrieve additional information are in process.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
It was reported that a patient with a 23mm 11500aj aortic pericardial valve has been placed under consideration for a valve-in-valve procedure after an implant duration of approximately four (4) years due to aortic stenosis and regurgitation.The patient presented with pressure gradient increase.
 
Manufacturer Narrative
Updated sections: a1, a2, a3, a4, b5, d4 serial number and expiration date, d6a, g3, g6, h4, h6 health effect - clinical code, device code(s), type of investigation, type of investigation, and investigation conclusions.The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Tissue degeneration-related structural deterioration, either calcific or non-calcific, are common chronic failure modes for this type of bioprosthetic heart valve.Operational mechanical stress and biological factors are generally believed to be the major contributors to the non-calcific bioprosthetic tissue degeneration.Structural valve deterioration (svd) can, and typically does, lead to chronic central leaks over a period of time.Svd is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes may occur singularly or concomitantly.A definitive root cause cannot be conclusively determined; however, patient factors likely caused or contributed.
 
Event Description
It was reported that a patient with a 23mm 11500aj aortic pericardial valve has been placed under consideration for a valve-in-valve procedure after an implant duration of four (4) years and two (2) months due to aortic stenosis and regurgitation secondary to structural valve deterioration.The patient presented with pressure gradient increase, heart failure, and dyspnea.The device was not returned for evaluation as it remained implanted.
 
Manufacturer Narrative
Updated sections: b5, g3, g6, and h6 health effect - impact code.
 
Event Description
It was reported that a patient with a 23mm 11500aj aortic pericardial valve underwent a valve-in-valve procedure after an implant duration of four (4) years, five (5) months due to aortic stenosis and regurgitation secondary to structural valve deterioration.The patient presented with pressure gradient increase, heart failure, and dyspnea.The procedure was performed with a 26mm 9755rsl transcatheter valve.The device was not returned for evaluation as it remained implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
irvine, CA 92614
9492506615
MDR Report Key17232347
MDR Text Key318178088
Report Number2015691-2023-14272
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/18/2020
Device Model Number11500AJ23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/07/2023
Initial Date FDA Received06/29/2023
Supplement Dates Manufacturer Received07/25/2023
09/28/2023
Supplement Dates FDA Received08/10/2023
10/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/19/2018
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Other;
Patient Age66 YR
Patient SexMale
Patient Weight69 KG
-
-